US Patent Issued to Orionis Biosciences, VIB VZW, Universiteit Gent on March 17 for "Fibroblast binding agents and use thereof" (Belgian, American Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,127, issued on March 17, was assigned to Orionis Biosciences Inc. (Waltham, Mass.), VIB VZW (Ghent, Belgium) and Universiteit Gent (Ghent, Belgium).

"Fibroblast binding agents and use thereof" was invented by Nikolai Kley (Waltham, Mass.), Jan Tavernier (Balegem, Belgium) and Anje Cauwels (Merelbeke, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates, in part, to agents that bind fibroblast activation protein (FAP) and their use as diagnostic and therapeutic agents. The present invention further relates to pharmaceutical compositions comprising the FAP binding agents and their use in the treatment of various diseas...